Therefore, as observed in both depression and obesity, disturbances in synaptic plasticity, and cognitive dysfunction may result from changes in the levels or action of both insulin and GLP-1; however, it is unclear whether this effect is due to their direct action or related to their effects on metabolic processes in these regions of the brain. This evidence concerns the gene GCG and obesity due to melanocortin 4 receptor deficiency.